|
🐜
|
TRIDENT-2: National Implementation of Genome-Wide Non-Invasive Prenatal Testing as a First-Tier Screening Test in the Netherlands.
40 auth.
K. V. D. van der Meij,
E. Sistermans,
M. Macville,
S. Stevens,
C. Bax,
M. Bekker,
C. Bilardo,
E. Boon,
M. Boter,
K. Diderich,
Christine E. M. de Die-Smulders,
L. Duin,
Brigitte H. W. Faas,
I. Feenstra,
M. C. Haak,
...
M. Hoffer,
N. D. den Hollander,
Iris H. I. M. Hollink,
F. Jehee,
M. Knapen,
A. Kooper,
I. V. van Langen,
K. Lichtenbelt,
I. Linskens,
M. V. van Maarle,
D. Oepkes,
M. Pieters,
G. H. Schuring-Blom,
E. Sikkel,
B. Sikkema‐Raddatz,
Dominique Smeets,
M. Srebniak,
R. F. Suijkerbuijk,
Gita Tan-Sindhunata,
A. van der Ven,
S. V. van Zelderen-Bhola,
L. Henneman,
R. Galjaard,
D. Van Opstal,
M. Weiss
|
8 |
2019 |
8
🐜
|
|
🐜
|
Trial by Dutch laboratories for evaluation of non‐invasive prenatal testing. Part I—clinical impact
20 auth.
D. Oepkes,
G. Page‐Christiaens,
C. Bax,
M. Bekker,
C. Bilardo,
E. Boon,
G. H. Schuring-Blom,
A. Coumans,
B. Faas,
R. Galjaard,
...
A. Go,
L. Henneman,
M. Macville,
E. Pajkrt,
R. Suijkerbuijk,
Karin Huijsdens–van Amsterdam,
D. Van Opstal,
E. J. Verweij,
M. Weiss,
E. Sistermans
|
7 |
2016 |
7
🐜
|
|
🐢
|
From Karyotyping to Array-CGH in Prenatal Diagnosis
K. Lichtenbelt,
N. Knoers,
G. H. Schuring-Blom
|
6 |
2011 |
6
🐢
|
|
🐬
|
Comparison of Multiplex Ligation-Dependent Probe Amplification and Karyotyping in Prenatal Diagnosis
E. Boormans,
E. Birnie,
D. Oepkes,
R. Galjaard,
G. H. Schuring-Blom,
J. V. van Lith
|
5 |
2010 |
5
🐬
|
|
🐢
|
Trends in the utilization of invasive prenatal diagnosis in The Netherlands during 2000–2009
7 auth.
K. Lichtenbelt,
B. Alizadeh,
P. Scheffer,
P. Stoutenbeek,
P. Schielen,
Lieve Page‐Christiaens,
...
G. H. Schuring-Blom
|
4 |
2011 |
4
🐢
|
|
🐜
|
Noninvasive Prenatal Test Results Indicative of Maternal Malignancies: A Nationwide Genetic and Clinical Follow-Up Study
23 auth.
C. J. Heesterbeek,
S. Aukema,
R. Galjaard,
E. Boon,
M. Srebniak,
K. Bouman,
B. Faas,
L. Govaerts,
M. Hoffer,
N. D. den Hollander,
...
K. Lichtenbelt,
M. V. van Maarle,
Lisanne van Prooyen Schuurman,
M. V. van Rij,
G. H. Schuring-Blom,
S. Stevens,
Gita Tan-Sindhunata,
M. Zamani Esteki,
C. D. de Die-Smulders,
V. Tjan-Heijnen,
L. Henneman,
E. Sistermans,
M. Macville
|
4 |
2022 |
4
🐜
|
|
🐜
|
Detection of fetal chromosomal anomalies: does nuchal translucency measurement have added value in the era of non‐invasive prenatal testing?
7 auth.
K. Lichtenbelt,
B. D. M. Diemel,
M. P. Koster,
G. Manten,
J. Siljee,
G. H. Schuring-Blom,
...
G. Page-Christiaens
|
4 |
2015 |
4
🐜
|
|
🐜
|
Factors determining uptake of invasive testing following first‐trimester combined testing
7 auth.
K. Lichtenbelt,
G. H. Schuring-Blom,
N. Burg,
G. Page-Christiaens,
N. Knoers,
P. Schielen,
...
M. Koster
|
4 |
2013 |
4
🐜
|
|
🐜
|
Novel Algorithms for Improved Sensitivity in Non-Invasive Prenatal Testing
12 auth.
L. Johansson,
E. N. Boer,
H. D. Weerd,
F. Dijk,
M. Elferink,
G. H. Schuring-Blom,
...
R. Suijkerbuijk,
R. Sinke,
G. Meerman,
R. Sijmons,
M. Swertz,
B. Sikkema‐Raddatz
|
4 |
2017 |
4
🐜
|
